EMSC announces pricing of public secondary offering by affiliates of Onex Corporation

Emergency Medical Services Corporation (NYSE: EMS) (“EMSC” or the “Company”) today announced that certain of its equity holders, primarily affiliates of Onex Corporation, have priced a public secondary offering of 8,000,000 shares (increased from 6,000,000) of class A common stock at $48.31 per share. The underwriters will have a 30-day option to purchase up to an additional 1,200,000 shares of class A common stock. The offering is expected to close on November 25, 2009, subject to customary closing conditions.

EMSC will not receive any proceeds from the offering. The shares are being offered primarily by affiliates of Onex Corporation (the “Onex Entities”). The Onex Entities’ shares represent approximately 35% of the Onex Entities’ equity interests in EMSC. After giving effect to this offering, the Onex Entities will own approximately 35% of the equity interests in EMSC and approximately 84% of the combined voting power, not including the impact of any exercise by the underwriters of the 30-day option to purchase additional shares of class A common stock. BofA Merrill Lynch, Goldman, Sachs & Co. and J.P. Morgan Securities Inc. are acting as joint bookrunners for the offering.

Source:

Emergency Medical Services Corporation

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.